Skip to main content
Top
Gepubliceerd in: Bijblijven 6/2017

23-08-2017

Anafylaxie en insectenallergie

Auteurs: A. van den Bosch, Dr. J. N. G. Oude Elberink

Gepubliceerd in: Bijblijven | Uitgave 6/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

In deze bijdrage wordt aandacht besteed aan anafylaxie, een potentieel levensbedreigende reactie op een exogene stimulus. In de meerderheid van de gevallen treden de klachten binnen twee uur na blootstelling op. Anafylaxie is een klinische diagnose. Het beloop van klachten, de criteria voor de diagnose anafylaxie en de acute behandeling worden beschreven, evenals het gebruik van de adrenaline auto-injectors. Vervolgens gaan we specifiek in op insectenallergie (met name wespenallergie) die bij 20 % van de bevolking voorkomt. De reacties kunnen variëren van een lokale zwelling tot een ernstige systemische reactie. Daarna geven we een overzicht van de verschillende reacties en de implicaties daarvan voor zowel diagnostiek als behandeling en wordt mastocytose besproken. De bijdrage wordt afgesloten met een negental praktische vragen.
Literatuur
1.
go back to reference Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026–45.CrossRefPubMed Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026–45.CrossRefPubMed
3.
go back to reference Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez-Rivas M, Cardona V, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69(10):1397–404.CrossRefPubMed Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez-Rivas M, Cardona V, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69(10):1397–404.CrossRefPubMed
4.
go back to reference Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78(1 Pt 1):76–83.CrossRefPubMed Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78(1 Pt 1):76–83.CrossRefPubMed
5.
go back to reference Douglas DM, Sukenick E, Andrade WP, Brown JS. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol. 1994;93(6):977–85.CrossRefPubMed Douglas DM, Sukenick E, Andrade WP, Brown JS. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol. 1994;93(6):977–85.CrossRefPubMed
6.
go back to reference Pumphrey RS. Fatal anaphylaxis in the UK, 1992–2001. Novartis Found Symp. 2004;257:116–28, discussion 128–32, 157–60, 276–85.CrossRefPubMed Pumphrey RS. Fatal anaphylaxis in the UK, 1992–2001. Novartis Found Symp. 2004;257:116–28, discussion 128–32, 157–60, 276–85.CrossRefPubMed
7.
go back to reference Campbell RL, Li JT, Nicklas RA, Sadosty AT, Members of the Joint Task Force, Practice Parameter Workgroup. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(6):599–608. doi:10.1016/j.anai.2014.10.007.CrossRefPubMed Campbell RL, Li JT, Nicklas RA, Sadosty AT, Members of the Joint Task Force, Practice Parameter Workgroup. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(6):599–608. doi:10.​1016/​j.​anai.​2014.​10.​007.CrossRefPubMed
8.
go back to reference Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10(4):354–61.CrossRefPubMed Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10(4):354–61.CrossRefPubMed
9.
go back to reference Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy. 2009;64(2):204–12.CrossRefPubMed Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy. 2009;64(2):204–12.CrossRefPubMed
10.
go back to reference Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005;95(3):217–26, quiz 226, 258.CrossRefPubMed Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005;95(3):217–26, quiz 226, 258.CrossRefPubMed
11.
go back to reference Oude Elberink JNG. Diagnostiek van insectenallergie. Ned Tijdschr Klin Chem Labgeneesk. 2008;33:11–6. Oude Elberink JNG. Diagnostiek van insectenallergie. Ned Tijdschr Klin Chem Labgeneesk. 2008;33:11–6.
12.
go back to reference Boeve MM, Rottier BL, Mandema JM, Rings EH, Kieboom JK, Dubois AE. Anafylaxie door pinda- en notenallergie bij 2 kinderen; aanbevelingen voor beleid. Ned Tijdschr Geneeskd. 2007;151:602–6.PubMed Boeve MM, Rottier BL, Mandema JM, Rings EH, Kieboom JK, Dubois AE. Anafylaxie door pinda- en notenallergie bij 2 kinderen; aanbevelingen voor beleid. Ned Tijdschr Geneeskd. 2007;151:602–6.PubMed
13.
14.
go back to reference Golden DB. Large local reactions to insect stings. J Allergy Clin Immunol Pract. 2015;3(3):331–4.CrossRefPubMed Golden DB. Large local reactions to insect stings. J Allergy Clin Immunol Pract. 2015;3(3):331–4.CrossRefPubMed
15.
go back to reference Golden DB, Kelly D, Hamilton RG, Craig TJ. Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol. 2009;123(6):1371–5.CrossRefPubMed Golden DB, Kelly D, Hamilton RG, Craig TJ. Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol. 2009;123(6):1371–5.CrossRefPubMed
16.
go back to reference Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. 2011;127(4):852–854.e23.CrossRefPubMed Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. 2011;127(4):852–854.e23.CrossRefPubMed
17.
go back to reference Bilo BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN, EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of hymenoptera venom allergy. Allergy. 2005;60(11):1339–49.CrossRefPubMed Bilo BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN, EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of hymenoptera venom allergy. Allergy. 2005;60(11):1339–49.CrossRefPubMed
18.
19.
go back to reference Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U, EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60(12):1459–70.CrossRefPubMed Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U, EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60(12):1459–70.CrossRefPubMed
20.
go back to reference Vos BJPR, Anrooij B van, Doormaal JJ van, Dubois AEJ, Oude Elberink JNG. Fatal Anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at-risk patients. J Allergy Clin Immunol Pract. 2017; doi:10.1016/j.jaip.2017.03.019.PubMed Vos BJPR, Anrooij B van, Doormaal JJ van, Dubois AEJ, Oude Elberink JNG. Fatal Anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at-risk patients. J Allergy Clin Immunol Pract. 2017; doi:10.​1016/​j.​jaip.​2017.​03.​019.PubMed
21.
go back to reference Oude Elberink JN, Monchy JG de, Golden DB, Brouwer JL, Guyatt GH, Dubois AE. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol. 2002;109(1):162–70.CrossRefPubMed Oude Elberink JN, Monchy JG de, Golden DB, Brouwer JL, Guyatt GH, Dubois AE. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol. 2002;109(1):162–70.CrossRefPubMed
22.
go back to reference Oude Elberink JN, Monchy JG de, Heide S van der, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol. 2002;110(1):174–82.CrossRefPubMed Oude Elberink JN, Monchy JG de, Heide S van der, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol. 2002;110(1):174–82.CrossRefPubMed
23.
go back to reference Oude Elberink JN, Heide S van der, Guyatt GH, Dubois AE. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. J Allergy Clin Immunol. 2006;118(3):699–704.CrossRefPubMed Oude Elberink JN, Heide S van der, Guyatt GH, Dubois AE. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. J Allergy Clin Immunol. 2006;118(3):699–704.CrossRefPubMed
24.
go back to reference Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, et al. Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009;123(3):680–6.CrossRefPubMed Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, et al. Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009;123(3):680–6.CrossRefPubMed
25.
go back to reference Anrooij B van, Veer E van der, Monchy JG de, Heide S van der, Kluin-Nelemans JC, Voorst Vader PC van, et al. Higher mast cell load decreases the risk of hymenoptera venom-induced anaphylaxis in patients with mastocytosis. J Allergy Clin Immunol. 2013;132(1):125–30.CrossRefPubMed Anrooij B van, Veer E van der, Monchy JG de, Heide S van der, Kluin-Nelemans JC, Voorst Vader PC van, et al. Higher mast cell load decreases the risk of hymenoptera venom-induced anaphylaxis in patients with mastocytosis. J Allergy Clin Immunol. 2013;132(1):125–30.CrossRefPubMed
26.
27.
go back to reference Doormaal JJ van, Arends S, Brunekreeft KL, Wal VB van der, Sietsma J, Voorst Vader PC van, et al. Prevalence of indolent systemic mastocytosis in a Dutch region. J Allergy Clin Immunol. 2013;131(5):1429–1431.e1.CrossRefPubMed Doormaal JJ van, Arends S, Brunekreeft KL, Wal VB van der, Sietsma J, Voorst Vader PC van, et al. Prevalence of indolent systemic mastocytosis in a Dutch region. J Allergy Clin Immunol. 2013;131(5):1429–1431.e1.CrossRefPubMed
28.
go back to reference Bonadonna P, Zanotti R, Muller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010;10(4):347–53.CrossRefPubMed Bonadonna P, Zanotti R, Muller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010;10(4):347–53.CrossRefPubMed
29.
go back to reference Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420–7. Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420–7.
30.
go back to reference Niedoszytko M, Bonadonna P, Oude Elberink JN, Golden DB. Epidemiology, diagnosis, and treatment of hymenoptera venom allergy in mastocytosis patients. Immunol Allergy Clin North Am. 2014;34(2):365–81.CrossRefPubMed Niedoszytko M, Bonadonna P, Oude Elberink JN, Golden DB. Epidemiology, diagnosis, and treatment of hymenoptera venom allergy in mastocytosis patients. Immunol Allergy Clin North Am. 2014;34(2):365–81.CrossRefPubMed
Metagegevens
Titel
Anafylaxie en insectenallergie
Auteurs
A. van den Bosch
Dr. J. N. G. Oude Elberink
Publicatiedatum
23-08-2017
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Bijblijven / Uitgave 6/2017
Print ISSN: 0168-9428
Elektronisch ISSN: 1876-4916
DOI
https://doi.org/10.1007/s12414-017-0247-5

Andere artikelen Uitgave 6/2017

Bijblijven 6/2017 Naar de uitgave

OriginalPaper

Handeczeem